An amanita muscaria extract – AME-1 – has been shown to hold anti-inflammatory properties in a Psyched Wellness study.
Preliminary data from Psyched Wellness’ study with the National Research Council of Canada (NRC) has indicated that AME-1 is anti-inflammatory.
The study is examining the anti-inflammatory properties of the AME-1 extract from the Amanita Muscaria mushroom by studying the effects of the extract on mast cells, which are important inflammatory cells present in the skin, gut, brain, and lungs.
Brian Tancowny, Scientific Advisor to Psyched, commented: “The preliminary evidence of the study reveals key nutritional systematic and functional properties of the AME-1 extract that may have the potential to provide anti-inflammatory health and wellness benefits.
“We will continue to investigate and seek to further understand the properties of the Amanita Muscaria mushroom and its anti-inflammatory properties.”
Prior research performed by the NRC had already shown that AME-1 inhibited mast cell activation of histamine release. The continued research has verified that pre-treatment of human mast cells with AME-1 results in the decrease of the release of pro-inflammatory mediators such as inflammatory cytokines.
“The anti-inflammatory properties and potential benefits of AME-1 as a natural product in reducing chronic inflammation are unique and novel,” added Jeff Stevens, CEO of the Company.
“We are excited about these findings and the potential they may have to help sufferers of conditions such as arthritis. We look forward to sharing more updates as additional studies are undertaken to further examine the mechanisms of the anti-inflammatory properties of the Amanita Muscaria mushroom.”
The Amanita Muscaria mushroom was recently added to the Natural Health Products Ingredients Database (NHPID) of Canada.
The NRC is an agency of the Government of Canada which specializes in providing vital scientific and technological services to the research and industrial communities of Canada.
Psyched Wellness engaged the NRC to provide their expertise in biomedical nanotechnology for the study, but all the results of the research will belong to Psyched, and the NRC does not endorse the findings or Psyched products.
[activecampaign form=52]
